A group of Ciphergen shareholders are drafting a no-confidence letter stating that they are dissatisfied with the company’s progress and share values, and that they seek to replace top management, ProteoMonitor has learned.
The shareholders are taking these steps after Ciphergen reported last week a 12.7-percent fall-off in total revenue during the fourth quarter of 2004.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
